SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

DALPIAZ, Alessandro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.614
AS - Asia 10.411
EU - Europa 5.306
SA - Sud America 1.641
Continente sconosciuto - Info sul continente non disponibili 335
AF - Africa 210
OC - Oceania 27
AN - Antartide 1
Totale 36.545
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.145
SG - Singapore 3.751
CN - Cina 2.485
BR - Brasile 1.252
IT - Italia 1.107
VN - Vietnam 1.053
UA - Ucraina 988
HK - Hong Kong 890
DE - Germania 736
TR - Turchia 595
GB - Regno Unito 540
BD - Bangladesh 430
FR - Francia 377
FI - Finlandia 341
SE - Svezia 316
IN - India 294
JP - Giappone 292
RU - Federazione Russa 257
PL - Polonia 241
CA - Canada 209
MX - Messico 160
AR - Argentina 135
ID - Indonesia 114
NL - Olanda 84
PK - Pakistan 81
CO - Colombia 77
ZA - Sudafrica 67
IQ - Iraq 64
EC - Ecuador 55
ES - Italia 55
AT - Austria 40
CL - Cile 40
UZ - Uzbekistan 38
LT - Lituania 36
BE - Belgio 35
IR - Iran 35
PH - Filippine 34
SA - Arabia Saudita 33
CZ - Repubblica Ceca 30
EG - Egitto 30
VE - Venezuela 30
TW - Taiwan 29
PY - Paraguay 28
MA - Marocco 26
MY - Malesia 26
AE - Emirati Arabi Uniti 25
JM - Giamaica 23
KR - Corea 23
KE - Kenya 21
CR - Costa Rica 20
TN - Tunisia 20
TH - Thailandia 18
AU - Australia 17
IE - Irlanda 16
CH - Svizzera 13
DZ - Algeria 13
NP - Nepal 13
RO - Romania 13
PE - Perù 12
AL - Albania 11
LB - Libano 10
NZ - Nuova Zelanda 10
DO - Repubblica Dominicana 9
ET - Etiopia 9
KZ - Kazakistan 9
RS - Serbia 9
AZ - Azerbaigian 8
BG - Bulgaria 8
HN - Honduras 8
IL - Israele 8
JO - Giordania 8
PS - Palestinian Territory 8
GR - Grecia 7
TT - Trinidad e Tobago 7
BA - Bosnia-Erzegovina 6
BO - Bolivia 6
DK - Danimarca 6
GT - Guatemala 6
HU - Ungheria 6
NI - Nicaragua 6
QA - Qatar 6
CI - Costa d'Avorio 5
KG - Kirghizistan 5
OM - Oman 5
PT - Portogallo 5
SY - Repubblica araba siriana 5
GE - Georgia 4
MK - Macedonia 4
NO - Norvegia 4
SV - El Salvador 4
XK - ???statistics.table.value.countryCode.XK??? 4
BS - Bahamas 3
BY - Bielorussia 3
EU - Europa 3
KW - Kuwait 3
ME - Montenegro 3
MN - Mongolia 3
NG - Nigeria 3
PA - Panama 3
PR - Porto Rico 3
Totale 36.171
Salva come PNG Salva come JPEG
Città #
Singapore 2.343
Ashburn 1.872
Woodbridge 1.450
San Jose 1.375
Fairfield 1.339
Houston 1.021
Jacksonville 1.013
Santa Clara 877
Hong Kong 866
Chandler 849
Beijing 722
Ann Arbor 616
Council Bluffs 555
Wilmington 555
Seattle 541
Cambridge 480
Ho Chi Minh City 373
Izmir 337
Nanjing 298
Hanoi 271
New York 270
Los Angeles 266
Tokyo 264
Ferrara 250
Dallas 228
Princeton 226
Warsaw 226
Boardman 188
Lauterbourg 187
Milan 160
The Dalles 150
San Diego 122
Munich 117
Helsinki 109
São Paulo 109
Addison 104
Nanchang 99
Mexico City 95
Orem 82
Shenyang 80
Chicago 78
Shanghai 77
Hefei 76
Buffalo 74
Hebei 74
London 72
Brooklyn 65
Jakarta 65
Tianjin 64
Toronto 59
Rio de Janeiro 57
Changsha 56
Rome 51
Montreal 50
Bremen 47
Chennai 47
Moscow 47
Falls Church 46
Frankfurt am Main 46
Redwood City 46
San Mateo 45
Dearborn 44
Atlanta 43
Phoenix 42
Da Nang 40
Bologna 39
Turku 38
Denver 37
Amsterdam 36
San Francisco 36
Kunming 35
Falkenstein 34
Jiaxing 34
Tashkent 34
Johannesburg 33
Norwalk 33
Stockholm 32
Manchester 30
Philadelphia 30
Boston 29
Haiphong 28
Mountain View 28
Naples 28
Ankara 27
Jinan 27
Belo Horizonte 26
Guangzhou 26
Medellín 26
Washington 26
Poplar 25
Vienna 25
Dhaka 24
Hải Dương 24
Mumbai 24
Brussels 23
Chongqing 23
Nuremberg 23
Zhengzhou 23
Columbus 22
Baghdad 21
Totale 23.505
Salva come PNG Salva come JPEG
Nome #
C- and N-terminal residue effect on peptide derivatives' antagonism toward the formyl-peptide receptor 405
A novel hybrid drug between two potent anti-tubulin agents as a potential prolonged anticancer approach 303
Application of the “in-oil nanoprecipitation” method in the encapsulation of hydrophilic drugs in PLGA nanoparticles 299
Indomethacin co-crystals and their parent mixtures: does the intestinal barrier recognize them differently? 291
Brain targeting of resveratrol by nasal administration of chitosan-coated lipid microparticles 279
Geraniol pharmacokinetics, bioavailability and its multiple effects on the liver antioxidant and xenobiotic-metabolizing enzymes 269
Ascorbic and 6-Br-ascorbic acid conjugates as a tool to increase the therapeutic effects of potentially central active drugs 259
Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity 253
Nose-to-brain delivery of antiviral drugs: A way to overcome their active efflux? 249
Conjugation of aspirin with vitamin C: uptake and stability studies 247
Development and characterization of biodegradable nanospheres as delivery systems of anti-ischemic adenosine derivatives. 242
Diclofenamic acid-vitamin C conjugates: stability and interaction studies with ascorbate transporters 234
Physicochemical stability of cabazitaxel and docetaxel solutions 230
Design, synthesis and activity of ascorbic acid prodrugs of nipecotic, kynurenic and diclophenamic acids, liable to increase neurotropic activity 228
Design, synthesis and in vitro evaluation on HRPE cells of ascorbic and 6-bromoascorbic acid conjugates with neuroactive molecules 227
Bile salt-coating modulates the macrophage uptake of nanocores constituted by a zidovudine prodrug and enhances its nose-to-brain delivery 227
Binding thermodynamics and intrinsic activity of adenosine A1 receptor ligands 225
A concerted binding study using binding measurements, X-ray structural data and molecular modeling on the stereochemical features responsible for the affinity of 6-arylpyrrolo[2,1-d][1,5]benzothiazepines to mitochondrial benzodiazepine receptors 224
Hyaluronic acid based-hybrid nanoparticles for targeted nose- to-brain delivery of dimethyl fumarate 218
Responses of peripheral blood mononucleated cells from non-celiac gluten sensitive patients to various cereal sources 218
Brain uptake of a Zidovudine prodrug after nasal administration of solid lipid microparticles 218
From Physical Mixtures to Co-Crystals: How the Coformers Can Modify Solubility and Biological Activity of Carbamazepine 217
Oxcarbazepine free or loaded PLGA nanoparticles as effective intranasal approach to control epileptic seizures in rodents 215
Binding thermodynamics at A1 and A2A adenosine receptors 212
An RPE cell line as a useful in vitro model for studying retinoic acid receptor beta: expression and affinity. 211
Transporter-mediated effects of diclofenamic acid and its ascorbyl pro-drug in the in vivo neurotropic activity of ascorbyl nipecotic acid conjugate 211
Allosteric modulation, thermodynamics and binding to wild-type and mutant (T277A) adenosine A 1 receptors of LUF5831, a novel nonadenosine-like agonist 211
Brain Targeting of an Antiischemic Agent by Nasal Administration of Microparticles 211
1H-pyrazolo[4,3-d]pyrimidine-7(6H)-one and 5H-pyrazolo[4,3-d] 1,2,3-triazin-4(3H)-one derivatives. Synthesis and in vitro biological activity at adenosine A1 and A2a receptors 211
Characterization and Hydrolysis Studies of a Prodrug Obtained as Ester Conjugate of Geraniol and Ferulic Acid by Enzymatic Way 207
Met-Ile-Phe-Leu derivatives: full and partial agonists of human neutrophil formylpeptide receptors 207
Binding thermodynamics of 5-HT(1A) receptor ligands 206
Nasal chitosan microparticles target a zidovudine prodrug to brain HIV sanctuaries 206
Can Thermodynamic Measurements of Receptor Binding Yield Information on Drug Affinity and Efficacy? 204
Receptor binding thermodynamics as a tool for linking drug efficacy and affinity 204
Development and characterization of PLGA nanoparticles as delivery systems of a prodrug of zidovudine obtained by its conjugation with ursodeoxycholic acid 204
Expression and characterization of vitamin C transporter in the human trophoblast cell line HTR-8/SVneo: Effect of steroids, flavonoids and NSAIDs 203
Chlorogenic acid permeation across intestinal cell monolayers: influence by circadian rhythms in the presence of other natural polyphenols and by dopaminergic neuronal-like cells 203
Conformational Aspects of Human Formyl-peptide Receptor Agonists 202
Characterisation of potential adenosine A1 receptor prodrugs of adenosine derivatives with antiischemic properties 202
Phe-D-Leu-Phe-D-Leu-Phe derivatives as formylpeptide receptor antagonists in human neutrophils: cellular and conformational aspects 197
Brain targeting of neuroactive drugs: studies of their transport mechanisms as conjugated with vitamin C or glucose. 195
[3H] CGS 21680 binding to purified adenosine A2A receptors in human platelets 194
Solid microparticles based on chitosan or methyl-beta-cyclodextrin: A first formulative approach to increase the nose-to-brain transport of deferoxamine mesylate 192
Chlorogenic acid permeation across intestinal cell monolayers: Influence by circadian rhythms in the presence of other natural polyphenols and by dopaminergic neuronal-like cells 191
Solid lipid microparticles for the stability enhancement of a dopamine prodrug 191
Bile acids modulation of nanoparticle macrophage uptake 191
Conformational aspects of human formylpeptide receptor antagonists 191
Progress in drug delivery to the central nervous system by the prodrug approach 190
Controlled release studies of antiischemic agents encapsulated in poly(lactic acid) nanoparticles. 190
[3H] SCH 58261 labels adenosine A2A receptors in human lymphocyte membranes 190
Dopamine-sensitive adenylyl cyclases in neuronal development: Physiopathological and pharmacological implications 189
Can pharmaceutical co-crystals provide an opportunity to modify the biological properties of drugs? 187
Exploring the use of spray congealing to produce solid dispersions with enhanced indomethacin bioavailability: In vitro characterization and in vivo study 187
Binding therodynamics and intrinsic activity of adenosine A1 receptor ligands: a model of their heart rate inhibition power. 186
Cationic liposomes carrying anti herpetic peptides as potential ocular vaccine 184
Uptake in the Central Nervous System of Geraniol Oil Encapsulated in Chitosan Oleate Following Nasal and Oral Administration 184
Adenosine analogs prodrugs: design, synthesis and chemico-physical characterization of N6-cyclopentyladenosine (CPA) derivatives 183
In Vitro Studies to Evaluate the Intestinal Permeation of an Ursodeoxycholic Acid-Conjugated Oligonucleotide for Duchenne Muscular Dystrophy Treatment 183
[3H] CGS 21680 binding to purified adenosine A2A receptors in human platelets 182
Vitamin C and 6-amino-vitamin C conjugates of diclofenac: synthesis and evaluation 181
Molecular mechanism involved in the transport of a prodrug dopamine glycosyl conjugate 179
Binding thermodynamics as a tool to investigate the mechanisms of drug-receptor interactions: Thermodynamics of cytoplasmic steroid/nuclear receptors in comparison with membrane receptors 178
Quantitative determination of zolmitriptan in rat blood and cerebrospinal fluid by reversed phase HPLC-ESI-MS/MS analysis: application to in-vivo preclinical pharmacokinetic study 178
N6-cyclopentyladenosine : selective brain targeting by nasal administration of microparticles 177
Binding thermodynamics of adenosine A2a receptor ligands 177
Polymeric nanoparticles as drug controlled release systems: a new formulation strategy for drugs with small or large molecular weight 176
N-ureido peptide derivatives as antagonists towar human neutrophil formylpeptide receptor 176
[3H] SCH 58261 labels adenosine A2A receptors in human lymphocyte membranes 172
Synthesis and biological evaluation of pro-drugs of GW196771, a potent glycine antagonist acting at the NMDA receptor 171
Particulate formulations based on chitosan for nose-to-brain delivery of drugs. A review 171
Effects of Microencapsulated Ferulic Acid or Its Prodrug Methyl Ferulate on Neuroinflammation Induced by Muramyl Dipeptide 171
Complementary use of flow and sedimentation field-flow fractionation techniques for size characterizing biodegradable poly(lactic acid) nanospheres 170
Poly(lactic acid) microspheres for the sustained release of antiischemic agents 170
Design and formulation of Eudragit-coated zein/pectin nanoparticles for the colon delivery of resveratrol 170
Studies on human neutrophil biological functions by means of formylpeptide receptor agonists and antagonists 169
Effect of chronic caffeine intake on A2A adenosine receptors in human neutrophils. 168
Binding thermodynamics and intrinsic activity of adenosine A1 receptor ligands: a model of their heart rate inhibition power. 166
A Novel Conjugated Agent between Dopamine and an A(2A) Adenosine Receptor Antagonist as a Potential Anti-Parkinson Multitarget Approach. 166
Effect of chronic caffeine intake on A2A adenosine receptors in human neutrophils. 165
Caffeine intake induces an alteration of human neutrophils A2A adenosine receptors. 165
From crystal to solution and across the membranes: the case of carbamazepine co-crystals 165
Uptake and stability studies of diclofenamic acid and its pro-drug obtained by conjugation with vitamin C 164
Drug release from pharmaceutical co-crystals: Are therapeutic and safety properties of active pharmaceutical substances retained? 164
Synthesis of naringenin-betaine cocrystal by gas antisolvent technique and cell models for in vitro permeation studies 163
Evidence for the presence of N-formyl-methionyl-leucyl-phenylalanine (fMLP) receptor ligands in human amniotic fluid and fMLP receptor modulation by physiological labour 163
Cancer stem cells and nanomedicine: new opportunities to combat multidrug resistance? 163
Full and partial agonists and thermodynamic binding parameters of adenosine A1 receptor ligands 162
Determination of the adenosine A1 agonist N6-cyclopentyladenosine in rat blood by solid-phase extraction and HPLC 162
Nasal administration and brain targeting of an antiischemic agent 161
Peptide derivatives as agonists or antagonists of formylpeptide receptors: analysis of their effects on neutrophils 161
Potential therapeutic effects of odorants through their ectopic receptors in pigmented cells 161
Exploring the Use of Spray Congealing to Produce Solid Dispersions with Enhanced Indomethacin Bioavailability 161
Coniugati dell’acido ascorbico ad attività neurotropica. 159
Adenosine A1 receptor: Analysis of the potential therapeutic effects obtained by its activation in the central nervous system 159
Temperature dependence and GABA modulation of β-carboline binding to rat cerebellum benzodiazepine receptors 158
Risedronate pharmacokinetic studies after oral administration to rats of loaded TiO2 nanoparticles 158
Prodrugs and Endogenous Transporters: Are They Suitable Tools for Drug Targeting into the Central Nervous System? 158
Thermodynamics of full agonist, partial agonist, and antagonist binding to wild-type and mutant adenosine A1 receptors 158
Cocrystals of Nitrofurantoin: How Coformers Can Modify Its Solubility and Permeability Across Intestinal Cell Monolayers 158
Totale 19.743
Salva come PNG Salva come JPEG
Categoria #
all - tutte 162.171
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.745
Totale 165.916
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.693 0 0 146 121 87 83 77 105 76 162 180 656
2022/20231.964 226 94 52 254 377 306 59 154 246 15 115 66
2023/2024990 121 131 57 24 94 111 35 38 15 19 33 312
2024/20254.784 98 90 380 190 609 428 191 295 723 581 710 489
2025/202613.717 1.234 579 1.166 1.697 1.755 839 1.470 808 1.413 1.577 658 521
2026/20271.779 557 787 435 0 0 0 0 0 0 0 0 0
Totale 36.545